Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer - Wang, Jinwan; Xu, Ruihua; Li, Jian; Bai, Yuxian; Liu, Tianshu; Jiao, Shunchang; Dai, Guanghai; Xu, Jianming; Liu, Yunpeng; Fan, Nanfeng; Shu, Yongqian; Ba, Yi; et al. (Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016)
Keywords: Abdominal Surgery; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Cancer Research; Cisplatin - administration & dosage; Cisplatin - adverse effects; Female; Fluorouracil - administration & dosage; Fluorouracil - adverse effects; Gastric cancer; Gastroenterology; Humans; Male; Medicine; Medicine & Public Health; Middle Aged; Neoplasm Recurrence, Local; Oncology; Original; Original Article; Stomach Neoplasms - drug therapy; Stomach Neoplasms - mortality; Stomach Neoplasms - pathology; Surgical Oncology; Survival Rate; Taxoids - administration & dosage; Taxoids - adverse effects; Treatment Outcome; Young Adult; Safety; Overall survival; Advanced gastric cancer; Progression-free survival; Modified docetaxel and cisplatin plus fluorouracil regimen